Revenue fell to $49.0M in 2026Q3 from $71.0M in 2024Q4 while gross margin swung between 37.2% and 53.0%, leaving a -22.8% operating margin that appears to be improving but remains deeply negative.
American Well Corporation (AMWL) annual income statement — 8-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 |
|---|
| Sales/Revenue | 211.23M | 249.32M | 254.36M | 259.05M | 277.19M | 252.79M | 245.26M | 148.86M | 113.95M |
| Revenue Growth % | -20.3% | -1.98% | -1.81% | -6.55% | 9.65% | 3.07% | 64.77% | 30.63% | - |
| Cost of Goods Sold | 114.14M | 116.47M | 155.41M | 164.29M | 160.42M | 148.47M | 156.79M | 79.98M | 58.61M |
| COGS % of Revenue | - | 46.71% | 61.1% | 63.42% | 57.87% | 58.73% | 63.93% | 53.73% | 51.43% |
| Gross Profit | 97.08M | 132.86M | 98.95M | 94.76M | 116.77M | 104.31M | 88.47M | 68.88M | 55.34M |
| Gross Margin % | 45.96% | 53.29% | 38.9% | 36.58% | 42.13% | 41.27% | 36.07% | 46.27% | 48.57% |
| Gross Profit Growth % | - | 34.27% | 4.42% | -18.85% | 11.94% | 17.9% | 28.45% | 24.46% | - |
| Operating Expenses | 155.91M | 238.13M | 316.49M | 786.9M | 392.62M | 283.46M | 315.91M | 163.59M | 110.45M |
| OpEx % of Revenue | - | 95.51% | 124.42% | 303.77% | 141.64% | 112.13% | 128.8% | 109.89% | 96.92% |
| Selling, General & Admin | 99.02M | 131.31M | 197.45M | 213.1M | 227.98M | 160.78M | 221.34M | 101.88M | 68.85M |
| SG&A % of Revenue | - | 52.67% | 77.62% | 82.27% | 82.25% | 63.6% | 90.25% | 68.44% | 60.42% |
| Research & Development | 46.27M | 72.86M | 86.06M | 105.83M | 138.49M | 106.59M | 84.41M | 53.94M | 36.27M |
| R&D % of Revenue | - | 29.22% | 33.84% | 40.85% | 49.96% | 42.17% | 34.42% | 36.24% | 31.83% |
| Other Operating Expenses | 583K | 33.96M | 32.98M | 467.97M | 26.15M | 16.09M | 10.15M | 7.76M | 5.33M |
| Operating Income | -58.83M | -105.27M | -217.53M | -692.14M | -275.85M | -179.15M | -227.43M | -94.7M | -55.11M |
| Operating Margin % | -27.85% | -42.22% | -85.52% | -267.19% | -99.52% | -70.87% | -92.73% | -63.62% | -48.36% |
| Operating Income Growth % | - | 51.61% | 68.57% | -150.91% | -53.98% | 21.23% | -140.15% | -71.86% | - |
| EBITDA | -30.42M | -71.31M | -184.56M | -660.63M | -249.69M | -163.06M | -217.28M | -86.94M | -49.78M |
| EBITDA Margin % | -14.4% | -28.6% | -72.56% | -255.02% | -90.08% | -64.5% | -88.59% | -58.41% | -43.68% |
| EBITDA Growth % | 65.9% | 61.36% | 72.06% | -164.58% | -53.13% | 24.95% | -149.91% | -74.67% | - |
| D&A (Non-Cash Add-back) | 28.41M | 33.96M | 32.97M | 31.51M | 26.17M | 16.09M | 10.15M | 7.76M | 5.33M |
| EBIT | -57.22M | -94.53M | -209.89M | -255.66M | -272.01M | -182.16M | -227.43M | -94.7M | -55.11M |
| Net Interest Income | 631K | 3.8M | 10.76M | 19.42M | 6.12M | 120K | 1.63M | 5.54M | 2.79M |
| Interest Income | 1.25M | 3.8M | 10.76M | 19.42M | 6.12M | 120K | 1.63M | 5.54M | 2.79M |
| Interest Expense | 617K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.58M | 10.74M | 7.65M | 16.83M | 3.85M | -3.01M | -556K | 5.54M | 2.79M |
| Pretax Income | -56.24M | -94.53M | -209.89M | -675.31M | -272.01M | -182.16M | -227.99M | -89.17M | -52.31M |
| Pretax Margin % | -26.63% | -37.92% | -82.51% | -260.69% | -98.13% | -72.06% | -92.96% | -59.9% | -45.91% |
| Income Tax | -188K | 434K | 2.75M | 3.86M | 64K | -5.38M | 639K | -803K | 0 |
| Effective Tax Rate % | 0.33% | -0.46% | -1.31% | -0.57% | -0.02% | 2.95% | -0.28% | 0.9% | 0% |
| Net Income | -57.1M | -95.7M | -208.14M | -675.16M | -270.43M | -176.33M | -224.43M | -87.19M | -52.67M |
| Net Margin % | -27.03% | -38.38% | -81.83% | -260.63% | -97.56% | -69.76% | -91.51% | -58.57% | -46.22% |
| Net Income Growth % | 49.66% | 54.02% | 69.17% | -149.66% | -53.36% | 21.43% | -157.41% | -65.53% | - |
| Net Income (Continuing) | -56.05M | -94.97M | -212.64M | -679.17M | -272.07M | -176.78M | -228.63M | -88.37M | -52.31M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 13.49M | 12.21M | 11.47M | 15.97M | 19.97M | 21.62M | 22.07M | 26.26M | 27.43M |
| EPS (Diluted) | -3.35 | -5.96 | -13.88 | -47.50 | -19.68 | -13.88 | -45.32 | -42.39 | -25.96 |
| EPS Growth % | 52.22% | 57.06% | 70.78% | -141.36% | -41.79% | 69.37% | -6.91% | -63.29% | - |
| EPS (Basic) | - | -5.96 | -13.88 | -47.50 | -19.68 | -13.88 | -45.32 | -42.39 | -25.96 |
| Diluted Shares Outstanding | 17.06M | 16.05M | 15M | 14.21M | 13.71M | 12.7M | 4.95M | 2.06M | 2.03M |
| Basic Shares Outstanding | 17.06M | 16.05M | 15M | 14.21M | 13.71M | 12.7M | 4.95M | 2.06M | 2.03M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying AMWL stock.
For fiscal year 2025, American Well Corporation (AMWL) reported total revenue of $249.3M. This represents a 118.8% increase compared to $114.0M in 2018.
American Well Corporation (AMWL) reported a net loss of $95.7M for the fiscal year ending 2025.
American Well Corporation (AMWL) reported an operating income of $-105.3M, resulting in an operating profit margin of -42.2%. This margin reflects the operational efficiency of the business before interest and taxes.
American Well Corporation (AMWL) generated $132.9M in gross profit for the year, representing a gross profit margin of 53.3%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Persistent operating losses
Metrics are mathematically derived from official filings.
Revenue Contraction Deepens Through 2026
According to reported quarterly figures, AMWL revenue fell to $49.0M in 2026Q3 from $71.0M in 2024Q4, with a year-over-year decline of 13.0% in the latest quarter, suggesting the top line has not yet stabilized.
The sequence from roughly $62-71M through 2025 to the $49-55M range in 2026 points to a sustained demand or pricing reset rather than a single weak quarter. Sequential declines in 2026Q2 and 2026Q3 reinforce that the contraction is ongoing and warrant investor attention on whether volume losses are concentrated in a particular customer or service line. Without segment disclosure in the supplied data, the driver of the decline cannot be isolated from the figures alone.
Gross Margin Volatility Undermines Pricing Stability
As reported in the quarterly figures, AMWL's gross margin swung between 37.2% and 53.0% across recent quarters, with 2026Q3 at 42.4%, indicating unstable unit economics rather than a durable pricing position.
Margin fluctuation of this magnitude is more consistent with variable delivery costs, revenue mix shifts, or one-time cost timing than with structural pricing power. The absence of a clear upward trend relative to 2024 levels of 37-48% suggests the company has not yet demonstrated sustained gross margin expansion. Investors should monitor whether recent gains persist, as the current data does not establish a durable cost advantage.
Operating Losses Persist Despite Cost Reduction
Per AMWL's reported figures, the operating margin improved from roughly -83% in 2024Q2 to -22.8% in 2026Q3, yet an operating loss of $11.2M remains, indicating scale has not yet reached breakeven.
The narrowing of operating losses reflects meaningful SG&A and R&D discipline, with SG&A falling from $50.2M in 2024Q4 to $22.8M in 2026Q3. However, operating income has not turned positive despite revenue being broadly flat, which suggests the cost base remains large relative to current revenue. Continued operating deficits imply the business still depends on cost action rather than revenue leverage to narrow losses.
Cost Cuts Could Mask Structural Demand Erosion
Based on AMWL's reported figures, the margin recovery may rest more on shrinking expenses than on durable revenue, a scenario short sellers would press as declining revenue and falling R&D raise questions about competitiveness.
If the sharp reductions in SG&A and R&D are partly a retreat from customer acquisition and product development, the improved operating margin could erode once cost actions are exhausted. Revenue has fallen about 31% from its 2024Q4 peak while the operating loss has narrowed, a combination that may indicate the margin improvement is largely cost-driven rather than evidence of a viable scaled model. Investors should treat the narrowing losses as provisional until revenue growth resumes.
Stock Compensation Weighs on Reported Losses
Stock-based compensation of $2.3M in 2026Q3 and $10.9M in 2024Q4 represents a material share of reported losses, which the supplied data suggests reflects non-cash charges that shape the headline loss figure.
Because SBC has declined substantially from the 2024 peak, part of the improvement in reported net loss likely reflects lower non-cash charges rather than operating improvement alone. Net loss of -$11.4M against operating loss of -$11.2M in 2026Q3 shows limited non-operating distortion, which makes the operating trend a reasonable proxy for earnings quality. Investors should weigh the dilution implications of equity compensation alongside the reported loss figures.